2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Swiss EE Study Group: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Off Label Use of Infliximab in Adult Patients With Severe Eosinophilic Esophagitis Infliximab - Esophagitis | Phase 2 | Completed | Swiss EE Study Group | 2007-08-01 | 2009-04-07 | |
| Budesonide for Eosinophilic Esophagitis Budesonide - Eosinophilic Esophagitis | Phase 2 | Completed | Swiss EE Study Group | 28 | 2005-12-01 | 2015-05-22 |
Eosinophilic Esophagitis (2) · Esophagitis (1)
Budesonide (1) · Infliximab (1)
Switzerland (2)
Alex Straumann, MD (1) · Christoph Beglinger, MD (1) · Hans-Uwe Simon, MD and PhD (1) · Hans-Uwe Simon, MD, PhD (1)